SCHEMBL7207337

SCHEMBL7207337

CCOC(=O)C(C(=O)OCC)C1(C)CCCCC1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
L3MBTL1 Q9Y468 1/20 0.35
KDM4E B2RXH2 5/20 0.35
HSD17B10 Q99714 2/20 0.34
LMNA P02545 1/20 0.34
ALOX15 P16050 2/20 0.33
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
SOAT1 P35610 1/20 0.33
NPSR1 Q6W5P4 2/20 0.33
MAPT P10636 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
METAP2 P50579 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14899077 0.91 ALDH1A1 (0.41) ALDH1A1L3MBTL1KDM4EHSD17B10LMNA
SCHEMBL7208245 0.91 ALDH1A1 (0.41) ALDH1A1L3MBTL1KDM4EHSD17B10LMNA
SCHEMBL9637790 0.90 ALDH1A1 (0.40) ALDH1A1L3MBTL1KDM4EHSD17B10LMNA
SCHEMBL8028102 0.89 ALDH1A1 (0.40) ALDH1A1L3MBTL1KDM4EHSD17B10LMNA
SCHEMBL26931966 0.81 ALDH1A1 (0.44) ALDH1A1L3MBTL1HSD17B10LMNAGAA
SCHEMBL11477925 0.80 ALDH1A1 (0.41) ALDH1A1L3MBTL1KDM4EHSD17B10LMNA
SCHEMBL7207409 0.79 NPSR1 (0.36) ALDH1A1LMNANPSR1MAPTMEN1
SCHEMBL11267533 0.78 ALDH1A1 (0.40) ALDH1A1L3MBTL1KDM4EHSD17B10ALOX15
SCHEMBL28098155 0.77 ALDH1A1 (0.39) ALDH1A1L3MBTL1KDM4EHSD17B10NPSR1
SCHEMBL8277962 0.77 ALDH1A1 (0.39) ALDH1A1L3MBTL1KDM4ELMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2995615-A1 CYCLOPROPYL-FUSED PYRROLIDINE-BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV AND THEIR PHARMACEUTICAL USE AstraZeneca AB (SE) 2016-03-16 EP disclosed
EP-2272825-B1 Protected amino hydroxy adamantane carboxylic acid and process for its preparation ASTRAZENECA AB (SE) 2015-11-04 EP disclosed
EP-1559710-B1 Dipeptidyl peptidase IV inhibitors based on cyclopropyl-fused pyrrolidine, process for their preparation and their use BRISTOL MYERS SQUIBB CO (US) 2014-02-26 EP disclosed
US-RE44186-E1 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method BRISTOL-MYERS SQUIBB COMPANY (US) 2013-04-30 US disclosed
EP-2272825-A2 N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation Bristol-Myers Squibb Company (US) 2011-01-12 EP disclosed
EP-1261586-B1 CYCLOPROPYL-FUSED PYRROLIDINE-BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV, PROCESSES FOR THEIR PREPARATION, AND THEIR USE BRISTOL MYERS SQUIBB CO (US) 2008-05-21 EP disclosed
US-6613934-B1 Enzymatic partial hydrolysis of a diester of malonic acid DEGUSSA AG (DE) 2003-09-02 US disclosed
EP-0812819-B1 Enantiomer-enriched tertiary hydrocarbonrest-substituted malonic acid ester and the preparation DEGUSSA (DE) 2001-11-28 EP disclosed
EP-0812819-A2 Enantiomer-enriched tertiary hydrocarbonrest-substituted malonic acid ester and the preparation HÜLS AKTIENGESELLSCHAFT (DE) 1997-12-17 EP disclosed